Liang Xu

5PUBLICATIONS
82CO-AUTHORS
Metabolic medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2026
Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.

|Mar 21, 2025
Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: A cohort study.

Rui Su, Xuemei Tao, Lihua Yan

|May 07, 2024
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma.

Jiaxin Han, Wentao Kuai, Liu Yang

|Feb 06, 2023
HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression.

Yufei Wang, Man Zhao, Lina Zhao

|Apr 01, 2022
Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination.

Lin Chen, Xuemei Tao, Youfei Zhao

Pageof 1

Frequent Collaborators

2 joint publications

Lin Chen

2 joint publications

Xuemei Tao

2 joint publications

Ningning Zhang

1 joint publications

Yufei Wang